Fig. 3.

Associations of remission, LLDAS and LLDAS/no remission with EQ-5D-3L, EQ-VAS and FACIT-Fatigue

Forest plots illustrating results from the quantile regression analyses. Number of visits refers to the number of visits in remission, LLDAS or LLDAS/no remission required to attain a clinically important benefit, based on the estimate derived from the regression model. The number of attainers refers to the actual number of patients who were in remission, LLDAS or LLDAS/no remission and attained a clinically important benefit in EQ-5D-3L and FACIT-Fatigue within the 52-week study follow-up. Number of patients for each analysis for remission and LLDAS were: EQ-5D (1642) and FACIT-Fatigue (1655). Number of patients for each analysis in LLDAS/no remission was: 1446 (i.e. number of patients after exclusion of patients who attained remission at one or more visits during the 52-week study). The total number of visits was 15 and they were scheduled every fourth week. LLDAS: lupus low disease activity state.